Spain Exocrine Pancreatic Insufficiency Diagnostics Market Size & Outlook
Related Markets
Spain exocrine pancreatic insufficiency diagnostics market highlights
- The Spain exocrine pancreatic insufficiency diagnostics market generated a revenue of USD 92.9 million in 2024 and is expected to reach USD 129.9 million by 2030.
- The Spain market is expected to grow at a CAGR of 5.8% from 2025 to 2030.
- In terms of segment, laboratory tests was the largest revenue generating diagnostic method in 2024.
- Laboratory Tests is the most lucrative diagnostic method segment registering the fastest growth during the forecast period.
Exocrine pancreatic insufficiency diagnostics market data book summary
| Market revenue in 2024 | USD 92.9 million |
| Market revenue in 2030 | USD 129.9 million |
| Growth rate | 5.8% (CAGR from 2025 to 2030) |
| Largest segment | Laboratory tests |
| Fastest growing segment | Laboratory Tests |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Laboratory Tests, Imaging Tests |
| Key market players worldwide | Certest Biotec, ScheBo Biotech, Immunodiagnostic Systems, Labcorp Holdings Inc, ALPCO Diagnostics, Quest Diagnostics Inc, Diasorin SpA, ARUP Laboratories, Verisana |
Other key industry trends
- In terms of revenue, Spain accounted for 2.6% of the global exocrine pancreatic insufficiency diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK exocrine pancreatic insufficiency diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 348.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Exocrine Pancreatic Insufficiency Diagnostics Market Scope
Exocrine Pancreatic Insufficiency Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Verisana | View profile | 11-50 | Hamburg, Hamburg, Germany, Europe | https://www.verisana.de/ |
| ALPCO Diagnostics | View profile | 11-50 | Salem, New Hampshire, United States, North America | https://www.alpco.com |
| ScheBo Biotech | View profile | 11-50 | Gießen, Hessen, Germany, Europe | https://www.schebo.de |
| Certest Biotec | View profile | - | Zaragoza, Aragon, Spain, Europe | http://www.certest.es/ |
| Immunodiagnostic Systems | View profile | 251-500 | Boldon, Durham, United Kingdom, Europe | http://www.idsplc.com |
| ARUP Laboratories | View profile | 1001-5000 | Salt Lake City, Utah, United States, North America | http://www.aruplab.com |
| Diasorin SpA | View profile | 3233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | https://www.diasoringroup.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
Spain exocrine pancreatic insufficiency diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to exocrine pancreatic insufficiency diagnostics market will help companies and investors design strategic landscapes.
Laboratory tests was the largest segment with a revenue share of 74.7% in 2024. Horizon Databook has segmented the Spain exocrine pancreatic insufficiency diagnostics market based on laboratory tests, imaging tests covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Spain exocrine pancreatic insufficiency diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spain exocrine pancreatic insufficiency diagnostics market databook
-
Our clientele includes a mix of exocrine pancreatic insufficiency diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain exocrine pancreatic insufficiency diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Spain exocrine pancreatic insufficiency diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Spain exocrine pancreatic insufficiency diagnostics market size, by diagnostic method, 2018-2030 (US$M)
Spain Exocrine Pancreatic Insufficiency Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
